Portfolio Companies
Co-founded by EMBLEM since 1999
We invest in core technologies that can be developed into successful, profitable businesses over time. The EMBL technology portfolio has generated more than 20 companies co-founded by EMBLEM since 1999 and new promising technologies continue to be established.
EMBLEM’s experience in founding new companies and our close working relationship EMBL’s collaboration partners in various industries provide the ideal environment for young start-ups. Please find a selection of our spin-off companies below.
Gene Bridges
Gene Bridges was founded in 2000, based on the Red/ET recombineering technology developed at EMBL. This technology enables cloning without the use of restriction enzymes. Genebridges provides kits for the …
PEPperPRINT
PEPperPRINT is an innovative biotech company founded in 2001. With their proprietary laser printing technology they established the new peptide microarray platform PEPperCHIP – a new standard in peptide microarrays. …
Savira pharmaceuticals
Savira pharmaceuticals – operating in Vienna, Austria – is focusing on the development of drugs for the treatment of influenza. Based on know-how and intellectual property from its co-founders, the …
Velabs Therapeutics
Established in late 2017, Velabs Therapeutics GmbH is EMBL’s most recent spin-off project. The company uses a proprietary high-throughput screening platform based on a broad portfolio of novel EMBL microfluidics …